$PMVC
PMV Consumer Acquisition Corp. Stock $pmvc

$pmvc Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000121390024027196 Filed on March 28, 2024

Income Statement

Concept	2023 Q4	2023
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit		-$269.9K
YoY Change		-74.58%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		-$71.96K
YoY Change		-100.82%
Income Tax		$36.19K
% Of Pretax Income
Net Earnings		-$108.1K
YoY Change		-101.25%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$1.073M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses	$129.5K
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.202M
YoY Change	-12.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$175.7K
YoY Change	-61.76%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$578.0K
YoY Change	18.01%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$578.0K
Total Long-Term Liabilities
Total Liabilities	$581.0K
YoY Change	-9.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$411.8K
YoY Change	35.61%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$621.1K
YoY Change
Total Liabilities & Shareholders Equity	$1.202M
YoY Change	-12.13%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income		-$108.1K
YoY Change		-101.25%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities		-$76.53K
YoY Change		-93.22%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities		-$76.53K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash		-$76.53K
YoY Change		-78.94%
FREE CASH FLOW
Cash From Operating Activities		-$76.53K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Entity File Number EntityFileNumber	001-39534
CY2023	dei	Entity Registrant Name EntityRegistrantName	PMV CONSUMER ACQUISITION CORP.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-5174573
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	249 Royal Palm Way
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 503
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Palm Beach
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33480
CY2023	dei	City Area Code CityAreaCode	(561)
CY2023	dei	Local Phone Number LocalPhoneNumber	318-3766
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	0	usd
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023	dei	Auditor Firm AuditorFirmId	100
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1072630	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1149157	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	42424	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	129474	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	176463	usd
CY2023Q4	us-gaap	Assets Assets	1202104	usd
CY2022Q4	us-gaap	Assets Assets	1368044	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	175745	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	187591	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	10259	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	30192	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	578004	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	489783	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2980	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	149000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	580984	usd
CY2022Q4	us-gaap	Liabilities Liabilities	638783	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1032917	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1032917	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-411807	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-303666	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	621120	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	729261	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1202104	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1368044	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	256691	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1031318	usd
CY2023	us-gaap	Franchisor Costs FranchisorCosts	13200	usd
CY2022	us-gaap	Franchisor Costs FranchisorCosts	30526	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-269891	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1061844	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1161232	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	51915	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-146020	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9388845	usd
CY2022	pmvc	Loss On Class B Shares Transferred Into Trust Account LossOnClassBSharesTransferredIntoTrustAccount	990000	usd
CY2022	pmvc	Forgiveness Of Deferred Underwriting Fee Payable ForgivenessOfDeferredUnderwritingFeePayable	-309312	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	197935	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	9869389	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-71956	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8807545	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36185	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	185192	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-108141	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	8622353	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-14194306	usd
CY2022	pmvc	Adjustments To Additional Paid In Capital Contribution Of Class B Founder Shares To Trust Account AdjustmentsToAdditionalPaidInCapitalContributionOfClassBFounderSharesToTrustAccount	990000	usd
CY2022	pmvc	Common Stock Issued At Redemption CommonStockIssuedAtRedemption	42424	usd
CY2022	pmvc	Remeasurement Adjustment To Amount Subject To Possible Redemption RemeasurementAdjustmentToAmountSubjectToPossibleRedemption	5268790	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	8622353	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	729261	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-108141	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	621120	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-108141	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	8622353	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1161232	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-146020	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9388845	usd
CY2022	pmvc	Loss On Class B Shares Transferred Into Trust Account LossOnClassBSharesTransferredIntoTrustAccount	990000	usd
CY2022	pmvc	Forgiveness Of Deferred Underwriting Fee Payable ForgivenessOfDeferredUnderwritingFeePayable	-309312	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-42424	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	42424	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-46989	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	73379	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-19933	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	30192	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-11846	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	83388	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	120000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	120000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-76527	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1129259	usd
CY2022	pmvc	Cash Withdrawn From Trust Account Pay Franchise And Income Taxes CashWithdrawnFromTrustAccountPayFranchiseAndIncomeTaxes	723496	usd
CY2022	pmvc	Cash Withdrawn From Trust Account To Redeem Investors CashWithdrawnFromTrustAccountToRedeemInvestors	175546898	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	176270394	usd
CY2022	pmvc	Redemption Of Common Stock RedemptionOfCommonStock	-175546898	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	42424	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-175504474	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-76527	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-363339	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1149157	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1512496	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1072630	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1149157	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	56383	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	155000	usd
CY2022	pmvc	Forgiveness Of Deferred Underwriting Fee Payable Allocated To Class A Common Stock ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassACommonStock	5815688	usd
CY2022	pmvc	Contribution Of Class B Common Stock To The Trust Account ContributionOfClassBCommonStockToTheTrustAccount	990000	usd
CY2022	pmvc	Conversion Of Class B Convertible Common Stock To Class A Convertible Common Stock ConversionOfClassBConvertibleCommonStockToClassAConvertibleCommonStock	7	usd
CY2023	pmvc	Conversion Of Class A Convertible Common Stock To Class C Common Stock ConversionOfClassAConvertibleCommonStockToClassCCommonStock	7	usd
CY2023	pmvc	Renaming Of Class C Common Stock To Class A Common Stock RenamingOfClassCCommonStockToClassACommonStock	7	usd
CY2023Q3	pmvc	Preferred Stock PreferredStock	20000000	shares
CY2022Q3	pmvc	Ownership Percentage OwnershipPercentage	0.20	pure
CY2023Q4	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	154874303	usd
CY2023Q4	pmvc	Redemption Common Stock Price Per Share RedemptionCommonStockPricePerShare	10.02
CY2023	pmvc	Interest Earned Income InterestEarnedIncome	340393	usd
CY2023	pmvc	Aggregate Amount Of Remaining Trust Account AggregateAmountOfRemainingTrustAccount	20511170	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	2042409	shares
CY2022Q4	pmvc	Redeemed Of Cash RedeemedOfCash	42424	usd
CY2023Q1	pmvc	Aggregate Purchase Price AggregatePurchasePrice	42000	shares
CY2023Q3	us-gaap	Share Price SharePrice	10
CY2023	pmvc	Public Warrants Exercisable PublicWarrantsExercisable	8750000	shares
CY2023	pmvc	Private Placement Warrants Exercisable PrivatePlacementWarrantsExercisable	6150000	shares
CY2023	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	140437	shares
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration:underline">Use of Estimates</span></i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration:underline">Concentration of Credit Risk</span></i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. Any loss incurred, or a lack of access to such funds, could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</p>
CY2023	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration:underline">Reclassification</span></i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The related party payables and accrued expenses have been reclassified for the prior year on the current year balance sheet for presentation purposes. No changes to the total assets, liabilities, or stockholder’s equity has been made.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2020Q1	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On August 3, 2020, the Company effected a 1.4-for-1 forward stock split of its issued and outstanding shares of Class B convertible common stock, resulting in an aggregate of 5,031,250 Founder Shares being outstanding, of which an aggregate of up to 656,250 shares were subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering.
CY2020Q3	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	656250	shares
CY2020Q3	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.20	pure
CY2023Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	42000	usd
CY2020Q3	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	10000	usd
CY2023	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	120000	usd
CY2022	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	120000	usd
CY2023Q4	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	392000	usd
CY2022Q4	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	272000	usd
CY2023Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	1067915	usd
CY2023Q4	pmvc	Investment Is Held Constant Per Unit InvestmentIsHeldConstantPerUnit	1
CY2023	pmvc	Underwriting Deferred Fee UnderwritingDeferredFee	0.35
CY2022Q3	pmvc	Deferred Underwriting Commission DeferredUnderwritingCommission	4593750	usd
CY2022Q4	pmvc	Forfeiture Remaining Deferred Underwriting Fee ForfeitureRemainingDeferredUnderwritingFee	1531250	usd
CY2023	pmvc	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	6125000	usd
CY2023Q4	pmvc	Forgiveness Of The Deferred Underwriting Fee Allocated To Public Shares ForgivenessOfTheDeferredUnderwritingFeeAllocatedToPublicShares	5815688	usd
CY2023	pmvc	Gain From Extinguishment Of Liability Allocated To Warrant Liabilities GainFromExtinguishmentOfLiabilityAllocatedToWarrantLiabilities	309312	usd
CY2022Q3	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	20000000	shares
CY2023	pmvc	Warrants For Redemption Description WarrantsForRedemptionDescription	●in whole and not in part; ●at a price of $0.01 per warrant; ●upon not less than 30 days’ prior written notice of redemption; ●if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and subject to adjustment as described below) for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and ●If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.
CY2023	pmvc	Total Outstanding Shares Percentage TotalOutstandingSharesPercentage	1	pure
CY2022Q4	pmvc	Total Outstanding Shares TotalOutstandingShares	100000	shares
CY2023Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	401781	usd
CY2022Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	347876	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	401781	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	347876	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	401781	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	347876	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	11133	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	185192	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-53905	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-164321	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	25052	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	53905	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	164321	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36185	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	185192	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.055	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.426	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.208	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.749	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.019	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.058	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.021	pure
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-3876345	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	990000	usd
CY2022Q4	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-990000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2023	pmvc	Loss On Class B Shares Transferred Into Trust Account LossOnClassBSharesTransferredIntoTrustAccount		usd
CY2023	pmvc	Forgiveness Of Deferred Underwriting Fee Payable ForgivenessOfDeferredUnderwritingFeePayable		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022	pmvc	Common Stock Founder Shares Converted CommonStockFounderSharesConverted		usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2023	pmvc	Loss On Class B Shares Transferred Into Trust Account LossOnClassBSharesTransferredIntoTrustAccount		usd
CY2023	pmvc	Forgiveness Of Deferred Underwriting Fee Payable ForgivenessOfDeferredUnderwritingFeePayable		usd
CY2023	pmvc	Cash Withdrawn From Trust Account Pay Franchise And Income Taxes CashWithdrawnFromTrustAccountPayFranchiseAndIncomeTaxes		usd
CY2023	pmvc	Cash Withdrawn From Trust Account To Redeem Investors CashWithdrawnFromTrustAccountToRedeemInvestors		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	pmvc	Redemption Of Common Stock RedemptionOfCommonStock		usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023	pmvc	Forgiveness Of Deferred Underwriting Fee Payable Allocated To Class A Common Stock ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassACommonStock		usd
CY2023	pmvc	Contribution Of Class B Common Stock To The Trust Account ContributionOfClassBCommonStockToTheTrustAccount		usd
CY2023	pmvc	Conversion Of Class B Convertible Common Stock To Class A Convertible Common Stock ConversionOfClassBConvertibleCommonStockToClassAConvertibleCommonStock		usd
CY2023	pmvc	Conversion Of Class B Convertible Common Stock To Class C Common Stock ConversionOfClassBConvertibleCommonStockToClassCCommonStock		usd
CY2022	pmvc	Conversion Of Class A Convertible Common Stock To Class C Common Stock ConversionOfClassAConvertibleCommonStockToClassCCommonStock		usd
CY2022	pmvc	Renaming Of Class C Common Stock To Class A Common Stock RenamingOfClassCCommonStockToClassACommonStock		usd
CY2022Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits		usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001807765

Files In Submission

Name	View Source	Status
0001213900-24-027196-index-headers.html	Edgar Link	pending
0001213900-24-027196-index.html	Edgar Link	pending
0001213900-24-027196.txt	Edgar Link	pending
0001213900-24-027196-xbrl.zip	Edgar Link	pending
f10k2023ex31-1_pmvconsumer.htm	Edgar Link	pending
f10k2023ex31-2_pmvconsumer.htm	Edgar Link	pending
f10k2023ex31-3_pmvconsumer.htm	Edgar Link	pending
f10k2023ex32-1_pmvconsumer.htm	Edgar Link	pending
f10k2023ex4-5_pmvconsumer.htm	Edgar Link	pending
f10k2023_pmvconsumer.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pmvc-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
pmvc-20231231_cal.xml	Edgar Link	unprocessable
pmvc-20231231_def.xml	Edgar Link	unprocessable
pmvc-20231231_lab.xml	Edgar Link	unprocessable
pmvc-20231231_pre.xml	Edgar Link	unprocessable
f10k2023_pmvconsumer_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMVC
PMV Consumer Acquisition Corp. Stock $pmvc

2023 Q4 Form 10-K Financial Statement

#000121390024027196 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMVC PMV Consumer Acquisition Corp. Stock $pmvc

2023 Q4 Form 10-K Financial Statement

#000121390024027196 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMVC
PMV Consumer Acquisition Corp. Stock $pmvc